- 1) Ikarashi Y, Yuzurihara M, Sakakibara I, Nakai Y, Hattori N, and Maruyama Y, Planta Med., 67, 709–713 (2001).
- 2) Zhang WW, Li Y, Wang XQ, Tian F, Cao H, Wang MW, and Sun QS, World J. Gastroenterol., 11, 4414–4418 (2005).
- 3) Lee MM, Hseih MT, Kuo JS, Yeh FT, and Huang HM, Neuroreport, 9, 3451–3456 (1998).
- 4) Ho KY, Tsai CC, Chen CP, Huang JS, and Lin CC, Phytother. Res., 15, 139–141 (2001).
- 5) Fong W-F, Tse AK, Poon K-H, and Wang C, Int. J. Biochem. Cell Biol., 37, 427–441 (2005).
- 6) Lin SY, Chang YT, Liu JD, Yu CH, Ho YS, Lee YH, and Lee WS, Mol. Carcinol., 32, 73–83 (2001).
- 7) Lin SY, Liu JD, Chang HC, Yeh SD, Lin CH, and Lee WS, J. Cell. Biochem., 84, 532–544 (2002).
- 8) Lowe JF and Frazee LA, Pharmacother., 26, 353–359 (2006).
- 9) Coleman RE, Cancer Treat. Rev., 27, 165–176 (2001).
- 10) Hall CL, Kang S, Macdougald OA, and Keller ET, J. Cell. Biochem., 97, 661–672 (2006).
- 11) Zha S, Yegnasubramanian V, Nelson WG, Isaacs WB, and De Marzo AM, Cancer Lett., 215, 1–20 (2004).
- 12) Warner TD and Mitchell JA, FASEB J., 18, 790–804 (2004).
- 13) Simmons DL, Botting RM, and Hla T, Pharmacol. Rev., 56, 387–437 (2004).
- 14) Yoshimura R, Sano H, Masuda C, Kawamura M, Tsubouchi Y, Chargui J, Yoshimura N, Hla T, and Wada S, Cancer, 89, 589–596 (2000).
- 15) Ferrandez A, Prescott S, and Burt RW, Curr. Pharm. Des., 9, 2229–2251 (2003).
- 16) Rich TA and Shepard R, Am. J. Clin. Oncol., 26, S110–S113 (2003).
- 17) Hussain T, Gupata S, Adhami VM, and Mukhtar H, Int. J. Cancer, 113, 660–669 (2005).
- 18) Sharma S, Yang SC, Zhu L, Reckamp K, Gardner B, Baratelli F, Huang M, Batra RK, and Dubinett SM, Cancer Res., 65, 5211–5220 (2005).
- 19) Tjandrawinata RR, Dahiya R, and Hughes-Fulford M, Br. J. Cancer, 75, 1111–1118 (1997).
- 20) Hughes-Fulford M, Chen Y, and Tjandrawinata RR, Carcinogenesis, 22, 701–707 (2001).
- 21) Nicolson GL, Biochem. Biophys. Acta, 948, 175–224 (1998).
- 22) Bajaj GK, Kleinberg L, and Terezakis S, Cancer Invest., 23, 363–376 (2005).
- 23) Liotta LA, Tryggvason K, Gabbisa S, Hart I, and Foltz CM, Nature, 284, 67–68 (1980).
- 24) Saikali Z and Singh G, Anticancer Drugs, 14, 773–778 (2003).
- 25) Leibovici D, Kamat AM, Pettaway CA, Pagliaro L, Rosser CJ, Logothetis C, and Pisters LL, J. Urol., 174, 2186–2190 (2005).
- 26) Bellon G, Martiny L, and Robinet A, Crit. Rev. Oncol. Hematol., 49, 203–220 (2004).
- 27) Minard ME, Kim LS, Price JE, and Gallick GE, Breast Cancer Res. Treat., 84, 21–32 (2004).
- 28) Valachovicova T, Slivova V, Bergman H, Shuherk J, and Sliva D, Int. J. Oncol., 25, 1389–1395 (2004).
- 29) Slivova V, Zaloga G, DeMichele SJ, Mukerji P, Huang YS, Siddiqui R, Harvey K, Valachovicova T, and Sliva D, Nutr. Cancer, 52, 66–73 (2005).
- 30) Hwang E and Lee HJ, Exp. Biol. Med., 231, 322–327 (2006).
- 31) Mook OR, Frederiks WM, and van Noorden CJ, Biochim. Biophys. Acta, 1705, 69–89 (2004).
- 32) Klein G, Vellenga E, Fraaije MW, Kamps WA, and de Bont ES, Crit. Rev. Oncol. Hematol., 50, 87–100 (2004).
- 33) Matchett MD, Mackinnon SL, Sweeney MI, Gottschall-Pass KT, and Hurta RA, J. Nutr. Biochem., 17, 117–125 (2006).
- 34) Roomi MW, Ivanov V, Netke S, Kalinovsky T, Niedzwiecki A, and Rath M, In Vivo, 20, 25–32 (2006).
- 35) Zucker S and Vacirca J, Cancer Metastasis Rev., 23, 101–117 (2004).
- 36) Yanagisawa N, Geironson L, Al-Soud WA, and Ljungh A, FEMS Immunol. Med. Microbiol., 44, 197–204 (2005).
- 37) Ikeda K and Nagase H, Biol. Pharm. Bull., 25, 1546–1549 (2002).
- 38) Yang SE, Hsieh MT, Tsai TH, and Hsu SL, Br. J. Pharmacol., 138, 193–201 (2003).
- 39) Attiga FA, Fernandez PM, Weeraratna AT, Manyak MJ, and Patierno SR, Cancer Res., 60, 4629–4637 (2000).
- 40) Xiong B, Sun TJ, Hu WD, Cheng FL, Mao M, and Zhou YF, World J. Gastroenterol., 11, 1105–1108 (2005).
- 41) Ikeda K, Sakai Y, and Nagase H, Phytother. Res., 17, 93–97 (2003).
- 42) Sun WH, Sun YL, Fang RN, Shao Y, Xu HC, Xue QP, Ding GX, and Cheng YL, Jpn. J. Clin. Oncol., 35, 707–713 (2005).
Full access
Magnolol Suppresses Metastasis via Inhibition of Invasion, Migration, and Matrix Metalloproteinase-2/-9 Activities in PC-3 Human Prostate Carcinoma Cells
Reprints and Corporate Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
To request a reprint or corporate permissions for this article, please click on the relevant link below:
Academic Permissions
Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?
Obtain permissions instantly via Rightslink by clicking on the button below:
If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.
Related research
People also read lists articles that other readers of this article have read.
Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.
Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.